Pharmacologic approaches for the management of patients with moderately elevated triglycerides (150-499 mg/dL).
Sign Up to like & getrecommendations! Published in 2017 at "Journal of clinical lipidology"
DOI: 10.1016/j.jacl.2017.05.014
Abstract: Hypertriglyceridemia, defined as serum triglyceride (TG) levels >150 mg/dL, now affects over one-quarter of the US adult population and is associated with an increased risk of atherosclerotic cardiovascular disease. Available guidelines for managing hypertriglyceridemia vary with… read more here.
Keywords: pharmacologic approaches; moderately elevated; approaches management; management ... See more keywords
Primary sclerosing cholangitis with moderately elevated serum‐IgG4 – characterization and outcome of a distinct variant phenotype
Sign Up to like & getrecommendations! Published in 2021 at "Liver International"
DOI: 10.1111/liv.15028
Abstract: Immunoglobulin G4‐associated cholangitis (IAC) is characterized by distinctly elevated immunoglobulin G4 in serum (sIgG4) and responds well to corticosteroid therapy. Primary Sclerosing Cholangitis (PSC) is a progressive liver disease without causal treatment options usually not… read more here.
Keywords: cholangitis; elevated serum; cholangitis moderately; sclerosing cholangitis ... See more keywords